10-86923365-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001406559.1(BMPR1A):​c.1418-11T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.299 in 1,613,372 control chromosomes in the GnomAD database, including 83,813 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 14930 hom., cov: 32)
Exomes 𝑓: 0.29 ( 68883 hom. )

Consequence

BMPR1A
NM_001406559.1 intron

Scores

2
Splicing: ADA: 0.00009420
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -0.227

Publications

22 publications found
Variant links:
Genes affected
BMPR1A (HGNC:1076): (bone morphogenetic protein receptor type 1A) The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. [provided by RefSeq, Jul 2008]
BMPR1A Gene-Disease associations (from GenCC):
  • generalized juvenile polyposis/juvenile polyposis coli
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Genomics England PanelApp
  • juvenile polyposis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • polyposis syndrome, hereditary mixed, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • hereditary mixed polyposis syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital heart defects, multiple types
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • pulmonary arterial hypertension
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 10-86923365-T-C is Benign according to our data. Variant chr10-86923365-T-C is described in ClinVar as Benign. ClinVar VariationId is 259286.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.679 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001406559.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BMPR1A
NM_004329.3
MANE Select
c.1343-11T>C
intron
N/ANP_004320.2
BMPR1A
NM_001406559.1
c.1418-11T>C
intron
N/ANP_001393488.1
BMPR1A
NM_001406560.1
c.1391-11T>C
intron
N/ANP_001393489.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BMPR1A
ENST00000372037.8
TSL:1 MANE Select
c.1343-11T>C
intron
N/AENSP00000361107.2
BMPR1A
ENST00000926286.1
c.1391-11T>C
intron
N/AENSP00000596345.1
BMPR1A
ENST00000480152.3
TSL:3
c.1343-11T>C
intron
N/AENSP00000483569.2

Frequencies

GnomAD3 genomes
AF:
0.402
AC:
61046
AN:
151858
Hom.:
14879
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.662
Gnomad AMI
AF:
0.229
Gnomad AMR
AF:
0.334
Gnomad ASJ
AF:
0.391
Gnomad EAS
AF:
0.698
Gnomad SAS
AF:
0.315
Gnomad FIN
AF:
0.374
Gnomad MID
AF:
0.367
Gnomad NFE
AF:
0.251
Gnomad OTH
AF:
0.386
GnomAD2 exomes
AF:
0.354
AC:
89039
AN:
251350
AF XY:
0.340
show subpopulations
Gnomad AFR exome
AF:
0.671
Gnomad AMR exome
AF:
0.366
Gnomad ASJ exome
AF:
0.372
Gnomad EAS exome
AF:
0.718
Gnomad FIN exome
AF:
0.371
Gnomad NFE exome
AF:
0.258
Gnomad OTH exome
AF:
0.314
GnomAD4 exome
AF:
0.288
AC:
421072
AN:
1461394
Hom.:
68883
Cov.:
34
AF XY:
0.287
AC XY:
208600
AN XY:
727018
show subpopulations
African (AFR)
AF:
0.684
AC:
22878
AN:
33462
American (AMR)
AF:
0.362
AC:
16170
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.376
AC:
9827
AN:
26126
East Asian (EAS)
AF:
0.711
AC:
28230
AN:
39690
South Asian (SAS)
AF:
0.304
AC:
26223
AN:
86246
European-Finnish (FIN)
AF:
0.362
AC:
19356
AN:
53406
Middle Eastern (MID)
AF:
0.367
AC:
2091
AN:
5690
European-Non Finnish (NFE)
AF:
0.249
AC:
276750
AN:
1111690
Other (OTH)
AF:
0.324
AC:
19547
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
16552
33105
49657
66210
82762
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9778
19556
29334
39112
48890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.402
AC:
61141
AN:
151978
Hom.:
14930
Cov.:
32
AF XY:
0.406
AC XY:
30175
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.662
AC:
27433
AN:
41440
American (AMR)
AF:
0.334
AC:
5101
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.391
AC:
1356
AN:
3464
East Asian (EAS)
AF:
0.699
AC:
3596
AN:
5148
South Asian (SAS)
AF:
0.315
AC:
1514
AN:
4808
European-Finnish (FIN)
AF:
0.374
AC:
3955
AN:
10562
Middle Eastern (MID)
AF:
0.381
AC:
112
AN:
294
European-Non Finnish (NFE)
AF:
0.251
AC:
17048
AN:
67950
Other (OTH)
AF:
0.387
AC:
818
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1628
3256
4883
6511
8139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.303
Hom.:
34418
Bravo
AF:
0.418
Asia WGS
AF:
0.487
AC:
1694
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
3
Juvenile polyposis syndrome (3)
-
-
3
not provided (3)
-
-
2
Generalized juvenile polyposis/juvenile polyposis coli (2)
-
-
2
Hereditary cancer-predisposing syndrome (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.8
DANN
Benign
0.32
PhyloP100
-0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000094
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7074064; hg19: chr10-88683122; API